Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The India home diagnostic testing market was valued at USD 411.83 Million in 2025. It is poised to grow at a CAGR of 4.80% during the forecast period of 2026-2035, reaching USD 658.16 Million by 2035. The market is driven by the rising prevalence of chronic diseases, growing consumer preference for at-home test kits, and expanding availability of rapid diagnostic tests through online and retail pharmacy channels.
Listed Indian diagnostic majors are positioned for healthy fourth-quarter FY26 earnings, with brokerage analysts forecasting double-digit revenue growth supported by accelerating demand for at-home sample collection and digital test bookings across metro and tier-two cities. According to The Economic Times, urban convenience trends, rising chronic disease screening, and platform-led aggregation continue to power the India home diagnostic testing market.
India's Central Drugs Standard Control Organisation issued an addendum to its In-Vitro Diagnostics FAQ guidance on March 13, 2026, providing fresh regulatory clarifications for IVD applicants seeking manufacturing and import licences. As published by the Central Drugs Standard Control Organisation, the update is expected to streamline approvals for self-test and home-use diagnostic kits, supporting expansion of the India home diagnostic testing market.
Compound Annual Growth Rate
4.8%
Value in USD Million
2026-2035
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The home diagnostic testing market encompasses self-administered test kits enabling individuals to monitor health conditions without clinical visits. Products span glucose monitoring devices, pregnancy test kits, cholesterol detection kits, infection testing kits, and rapid antigen tests. The market in India was valued at USD 411.83 Million in 2025 and is witnessing steady growth owing to increasing diabetes incidence, expanding retail and online pharmacy networks, and rising demand for preventive healthcare solutions. Government healthcare initiatives and the growing accessibility of rapid diagnostic products are also contributing to broader market expansion across urban and semi-urban regions.
Rising Chronic Disease Burden to Boost the Market Demand
The escalating prevalence of diabetes, cardiovascular disease, and other non-communicable conditions is the primary demand driver for the market. The rising awareness regarding early disease detection and routine glucose monitoring has encouraged greater adoption of at-home diagnostic kits among urban and semi-urban populations. According to the International Diabetes Federation (IDF) Diabetes Atlas 2025, approximately 589 million adults aged 20–79 years were living with diabetes globally in 2024, and the number is projected to reach 853 million by 2050. The growing need for early diagnosis and continuous monitoring is expected to strengthen demand for home diagnostic testing products in India.
The market is witnessing several emerging trends, including rapid adoption of digital diagnostics and expansion of home-based healthcare services.
Rapid Expansion of At-Home Digital Diagnostic Services is Expected to Improve the Market Growth
The growing preference for convenient and technology-enabled healthcare solutions is accelerating the adoption of at-home diagnostic testing services across India. Consumers are increasingly seeking faster sample collection, digital reporting, and integrated healthcare platforms that support preventive care and chronic disease management. For instance, in June 2025, Amazon India launched Amazon Diagnostics across six Indian cities in partnership with Orange Health Labs, offering doorstep sample collection and rapid digital test reports through the Amazon app. Such developments are expected to strengthen accessibility and consumer confidence, thereby supporting the long-term growth of the market.
Market Breakup by Test Type
Market Breakup by Product
Market Breakup by Sample
Market Breakup by Age Group
Market Breakup by Distribution Channel
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Infectious Disease Testing Segment is Expected to Witness Strong Growth by Test Type
The market is segmented based on test type into HIV test kits, diabetes and glucose test, cholesterol and triglycerides tests, pregnancy tests, infectious disease tests, urinary tract infection tests, ovulation predictor test kits, and others. Among these, the infectious disease tests segment is expected to witness substantial growth owing to the increasing prevalence of viral and sexually transmitted infections and the growing preference for rapid at-home screening solutions. According to De Partha et al., 2025, the prevalence of high-risk HPV infection among healthy women ranged between 7% and 27%, while nearly 31% of Indian males were affected by genital HPV infections. The rising focus on early detection and preventive healthcare is expected to further accelerate demand for infectious disease home diagnostic kits.
The key features of the market report include strategic initiatives by the leading players. The major companies in the market are as follows:
Becton, Dickinson and Company recently expanded its presence in the market through the launch of its BD Onclarity™ HPV Self-Collection solution. The company introduced an at-home HPV testing workflow integrated with the BD COR™ System, enabling simplified self-sample collection and automated laboratory processing. This development strengthens BD’s role in advancing accessible and efficient home-based diagnostic screening solutions.
Abbott is a major participant in the market, offering rapid at-home and point-of-care diagnostic solutions. Its portfolio includes the BinaxNOW COVID-19/Flu A&B Combo Self Test and FreeStyle Libre continuous glucose monitoring systems for diabetes management. The company continues to strengthen its diagnostics segment through reliable self-testing technologies designed for convenient home healthcare monitoring.
QuidelOrtho Corporation plays an important role in the home diagnostic testing market with its broad portfolio of rapid diagnostic and infectious disease testing solutions. The company provides diagnostic products supporting healthcare providers, laboratories, and home-testing applications across more than 140 countries. Its focus on accessible diagnostic technologies strengthens its position in the expanding global home testing industry.
F. Hoffmann-La Roche is actively involved in the market through its patient self-testing and point-of-care diagnostic solutions. The company’s CoaguChek® systems support INR self-monitoring for patients requiring anticoagulation therapy, enabling convenient at-home coagulation testing. Roche continues to enhance patient-centered diagnostics through digital and self-testing technologies that improve treatment monitoring and healthcare efficiency.
Other key players include Nova Biomedical, Siemens Healthcare GmbH, ACON Laboratories, Inc., BTNX, Inc., and Medtronic plc.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test Type |
|
| Breakup by Product |
|
| Breakup by Sample |
|
| Breakup by Age Group |
|
| Breakup by Distribution Channel |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.